Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Deep dive into TRI-PCI: big data to clinical practice

13 Dec 2020 – From AICT-AsiaPCR 2020

Watch this session to understand the value of big data, to learn and gain confidence in TRI for complex PCI cases and to discuss the intricacies of TRI-PCI with the experts.

This session was originally presented during AICT-AsiaPCR 2020.

Deep dive into TRI-PCI: Big data to clinical practice

The year in review in Interventional Cardiology: clinical trials and relevant literature published in 2020

12 Dec 2020 – From GulfPCR-GIM 2020

Watch this session if you want to reflect on key learnings for clinical practice from selected trials published in 2020, to get a rapid overview of the most relevant literature of the year in the fields of coronary, valvular and peripheral interventions and to see examples...

The year in review in Interventional Cardiology

Three-dimensional optical coherence tomography-guided double kissing crush stenting

14 Dec 2020

The authors present a case of percutaneous coronary intervention for bifurcation lesion in a 73-year-old man suffering from effort angina, in which they successfully performed double kissing crush stenting using optical coherence tomography.

Image in cardiology: OCT-guided crush stenting

Editorial - The “Interventional cardiac surgeon”: the (new) member of the interventional Heart Team

18 Nov 2020

Surgeons have been for many years the only interventionalists. The only “doctors” to dare enter the body and mechanically intervene on structures to cure or improve quality of life. The link between surgeons and interventional cardiologists is very strong. Many surgeons contributed to the development of...

Prof. Francesco Maisano

Author

Francesco Maisano
William Wijns

Author

William Wijns

Author

Salvatore Brugaletta
The “Interventional cardiac surgeon”: the (new) member of the interventional Heart Team

Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD

27 Oct 2020

The ASET pilot study: a multicenter, single-arm, first-in-human and proof-of-concept trial which included a total of 212 low-risk patients with stable coronary artery disease

Reviewer

Ali Nazmi Calik
Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD

OPTIMIZE IDE: A randomized trial of a novel, ultra low profile fixed-wire DES

26 Oct 2020

At TCT Connect 2020, Late-Breaking Trial Session IV, the primary results of the OPTIMIZE IDE were presented by Dean J. Kereiakes. Daniele Giacoppo provides a summary of the trial.

Daniele Giacoppo

Author

Daniele Giacoppo
Live from TCT Connect 2020: The OPTIMIZE trial

Evidence counts: latest Renal Denervation data and the Onyx ONE month DAPT program

19 Oct 2020

On this page you will find a selection of interviews regarding the latest data on renal denervation from TCT Connect 2020, as well as the latest complex sub-analyses from the Onyx ONE Month DAPT program. View a series of short interviews here below!

Evidence counts: latest data from Renal Denervation and the Onyx ONE month DAPT program

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome

06 Oct 2020

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Prasugrel-based de-escalation of DAPT after PCI in patients with ACS

Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020

19 Oct 2020

Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!

Vijay Kunadian

Author

Vijay Kunadian
 #TCTConnect 2020 summary and take home messages

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!

17 Oct 2020

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.

Author

Hector Garcia
Live from TCT Connect 2020: PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB